isoliquiritigenin

Isoliquiritigenin is a lipid of Polyketides (PK) class. Isoliquiritigenin is associated with abnormalities such as abnormal fragmented structure, Gastric ulcer, Gastric mucosa lesion, Peptic Ulcer and Wiskott-Aldrich Syndrome. The involved functions are known as Mass-to-Charge Ratio, Anabolism, Oxidation, inhibitors and Energy Absorption. Isoliquiritigenin often locates in Microsomes, Liver, Hepatic, Microsomes, Immune system and Vacuole. The associated genes with Isoliquiritigenin are P4HTM gene, BCL2 gene, AP1AR gene, oxytocin, 1-desamino-(O-Et-Tyr)(2)- and ODAM gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of isoliquiritigenin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with isoliquiritigenin?

isoliquiritigenin is suspected in Gastric mucosa lesion, Gastric ulcer, Peptic Ulcer, Nodule, Infertility and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with isoliquiritigenin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Glioma D005910 112 associated lipids
Weight Loss D015431 56 associated lipids
Precancerous Conditions D011230 48 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Leiomyoma D007889 8 associated lipids
Choroidal Neovascularization D020256 5 associated lipids
Carcinoma, Adenoid Cystic D003528 3 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with isoliquiritigenin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with isoliquiritigenin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with isoliquiritigenin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with isoliquiritigenin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with isoliquiritigenin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with isoliquiritigenin?

Knock-out

Knock-out are used in the study 'Two activators of in vitro fertilization in mice from licorice.' (Tung NH et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with isoliquiritigenin

Download all related citations
Per page 10 20 50 100 | Total 275
Authors Title Published Journal PubMed Link
Yang N et al. Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMIâ„¢, inhibit memory Th2 responses in vitro and in vivo. 2013 Phytother Res pmid:23165939
Li X et al. A new flavonol from Oxytropis ochrocephala Bunge. 2013 Nat. Prod. Res. pmid:22494026
Foresti R et al. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. 2013 Pharmacol. Res. pmid:23942037
Yuan X et al. Involvement of endoplasmic reticulum stress in isoliquiritigenin-induced SKOV-3 cell apoptosis. 2013 Recent Pat Anticancer Drug Discov pmid:22963151
Lorusso V and Marech I Novel plant-derived target drugs: a step forward from licorice? 2013 Expert Opin. Ther. Targets pmid:23425066
Simmler C et al. Dynamic residual complexity of the isoliquiritigenin-liquiritigenin interconversion during bioassay. 2013 J. Agric. Food Chem. pmid:23427769
Lee SK et al. The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction. 2013 Phytother Res pmid:23401151
Hajirahimkhan A et al. Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms. 2013 PLoS ONE pmid:23874474
Chen H et al. Isoliquiritigenin-induced effects on Nrf2 mediated antioxidant defence in the HL-60 cell monocytic differentiation. 2013 Cell Biol. Int. pmid:23881796
Zhao H et al. Isoliquiritigen enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide. 2013 Molecules pmid:23887720
Chen YP et al. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase. 2013 Eur J Med Chem pmid:23786711
Zhang XY et al. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. 2013 Eur J Pharm Sci pmid:23624327
Arai T et al. Rikkunshito and isoliquiritigenin counteract 5-HT-induced 2C receptor-mediated activation of pro-opiomelanocortin neurons in the hypothalamic arcuate nucleus. 2013 Neuropeptides pmid:23756052
Yamada C et al. Rikkunshito, a Japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model. 2013 Biomed Res Int pmid:24288687
Robinson SJ et al. Selected furanochalcones as inhibitors of monoamine oxidase. 2013 Bioorg. Med. Chem. Lett. pmid:23860591
Wang Z et al. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. 2013 PLoS ONE pmid:23861918
Li Y et al. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. 2013 Toxicol. Appl. Pharmacol. pmid:23747687
Zhang X et al. Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway. 2013 Mediators Inflamm. pmid:24163504
Lee YK et al. Pharmacokinetics of isoliquiritigenin and its metabolites in rats: low bioavailability is primarily due to the hepatic and intestinal metabolism. 2013 Planta Med. pmid:24108436
Hirchaud F et al. Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca Ski cells. 2013 Planta Med. pmid:24214831